Local assembly and installation efforts are advancing Hai Long towards its delivery target of more than 1GW of offshore wind ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...